Who is sponsoring NCT03392025?

NCT03392025 is sponsored by Javad Nasrollahzadeh.

What condition does NCT03392025 study?

NCT03392025 studies Coronary Artery Disease.

What drugs are being tested in NCT03392025?

Interventions: Flaxseed, the Mediterranean-like diet, Placebo.

What is the status of NCT03392025?

NCT03392025 is currently COMPLETED.

Last reviewed 2018-09-07 · How we verify

Flaxseed Consumption, Alone and in Combination With the Mediterranean-like Diet, on Some Indicators Related to Atherosclerosis

NCT03392025 NA COMPLETED

Flaxseed consumption has beneficial effects on cardiovascular risk factors. In addition, the benefit of the Mediterranean-like diet in primary and secondary prevention of cardiovascular diseases has been shown.The purpose of this study is to investigate the effects of flaxseed consumption, alone and in combination with the Mediterranean-like diet, in adjunct to conventional medical treatment, in improving vascular endothelial function, plasma lipid profile and high sensitivity c-reactive protein of coronary artery disease (CAD) patients.

Details

Lead sponsor	Javad Nasrollahzadeh
Phase	NA
Status	COMPLETED
Enrolment	87
Start date	Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Sep 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Coronary Artery Disease

Interventions

Flaxseed
the Mediterranean-like diet
Placebo

Countries

Iran